Bassam A Elgamoudi

Dr. Bassam A Elgamoudi

Griffith University, Gold Coast, Queensland, Australia
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Science Signaling
Verified
Journal Article
Closed access
BEBassam A Elgamoudi
Bassam A Elgamoudi
EAEkaterina P. Andrianova
Ekaterina P. Andrianova
LSLucy K. Shewell
Lucy K. Shewell
CDChristopher Day
Christopher Day
RKRebecca M. King
Rebecca M. King
Victoria KorolikVictoria Korolik
Victoria Korolik
Two ligand-binding sites in a chemoreceptor enable a human bacterial pathogen to adapt to hosts.

20 August 2008 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
AEA. Etoumi
A. Etoumi
IMI. El Musrati
I. El Musrati
BEBassam A Elgamoudi
Bassam A Elgamoudi
MBM. El Behlil
M. El Behlil
Crude oil with different concentrations was subjected to Pseudomonas species at 37 °C and various incubation periods. The results showed that Pseudomonas species grew faster at 1% (v/v) concentration of crude oil and exhibited high biodegradation ability within 1 week. On measuring the emulsification activity and emulsion stability during different stages of growth, in various immiscible hydrocarbons, it appeared that the species was able to produce a stable emulsion with a maximum at the end of stationary phase of growth. The gas chromatography analysis of the saturated hydrocarbons of crude oil showed that, an increase in concentration of iso-alkanes in the range of C15–C20, and a bioconversion of heavy iso-alkanes in the range of C21–C22+. Chemical analysis of crude oil by liquid chromatographic technique before and after growth showed that, the saturated alkanes were more degradable than aromatic and asphaltenic compounds. Treatment by Pseudomonas species may possibly be an effective method for the biodegradation of heavy paraffinic hydrocarbon leading to an enhancement in crude oil properties.

Verified
Journal Article
Open access
PDF file
BEBassam A Elgamoudi
Bassam A Elgamoudi
Victoria KorolikVictoria Korolik
Victoria Korolik
Microbial biofilms occur naturally in many environmental niches and can be a significant reservoir of infectious microbes in zoonotically transmitted diseases such as that caused by Campylobacter jejuni, the leading cause of acute human bacterial gastroenteritis world-wide. The greatest challenge in reducing the disease caused by this organism is reducing transmission of C. jejuni to humans from poultry via the food chain. Biofilms enhance the stress tolerance and antimicrobial resistance of the microorganisms they harbor and are considered to play a crucial role for Campylobacter spp. survival and transmission to humans. Unconventional approaches to control biofilms and to improve the efficacy of currently used antibiotics are urgently needed. This review summarizes the use plant- and microorganism-derived antimicrobial and antibiofilm compounds such as essential oils, antimicrobial peptides (AMPs), polyphenolic extracts, algae extracts, probiotic-derived factors, d-amino acids (DAs) and glycolipid biosurfactants with potential to control biofilms formed by Campylobacter, and the suggested mechanisms of their action. Further investigation and use of such natural compounds could improve preventative and remedial strategies aimed to limit the transmission of campylobacters and other human pathogens via the food chain.

31 August 2021 in mBio
Verified
Journal Article
Open access
KJKevin S Johnson
Kevin S Johnson
BEBassam A Elgamoudi
Bassam A Elgamoudi
FJFreda E-C Jen
Freda E-C Jen
CDChristopher J Day
Christopher J Day
ESEmily Goers Sweeney
Emily Goers Sweeney
KOKaren M. Ottemann
Karen M. Ottemann
Numerous chemotactic bacterial pathogens depend on the ability to sense a diverse array of signals through chemoreceptors to achieve successful colonization and virulence within their host. The signals sensed by chemoreceptors, however, are not always fully understood.

23 November 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
BEBassam A Elgamoudi
Bassam A Elgamoudi
TTTaha Taha
Taha Taha
Victoria KorolikVictoria Korolik
Victoria Korolik
The ability of bacterial pathogens to form biofilms is an important virulence mechanism in relation to their pathogenesis and transmission. Biofilms play a crucial role in survival in unfavorable environmental conditions, acting as reservoirs of microbial contamination and antibiotic resistance. For intestinal pathogen Campylobacter jejuni, biofilms are considered to be a contributing factor in transmission through the food chain and currently, there are no known methods for intervention. Here, we present an unconventional approach to reducing biofilm formation by C. jejuni by the application of D-amino acids (DAs), and L-amino acids (LAs). We found that DAs and not LAs, except L-alanine, reduced biofilm formation by up to 70%. The treatment of C. jejuni cells with DAs changed the biofilm architecture and reduced the appearance of amyloid-like fibrils. In addition, a mixture of DAs enhanced antimicrobial efficacy of D-Cycloserine (DCS) up to 32% as compared with DCS treatment alone. Unexpectedly, D-alanine was able to reverse the inhibitory effect of other DAs as well as that of DCS. Furthermore, L-alanine and D-tryptophan decreased transcript levels of peptidoglycan biosynthesis enzymes alanine racemase (alr) and D-alanine-D-alanine ligase (ddlA) while D-serine was only able to decrease the transcript levels of alr. Our findings suggest that a combination of DAs could reduce biofilm formation, viability and persistence of C. jejuni through dysregulation of alr and ddlA.

5 March 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
LLLena Hoang My Le
Lena Hoang My Le
BEBassam A Elgamoudi
Bassam A Elgamoudi
NCNina Colon
Nina Colon
ACAngus Cramond
Angus Cramond
FPFrederic Poly
Frederic Poly
RFRichard L. Ferrero
Richard L. Ferrero
Cytolethal distending toxins (CDTs) are released by Gram-negative pathogens into the extracellular medium as free toxin or associated with extracellular vesicles (EVs), commonly known as outer membrane vesicles (OMVs). CDT production by the gastrointestinal pathogen Campylobacter jejuni has been implicated in colorectal tumorigenesis. Despite CDT being a major virulence factor for C. jejuni , little is known about the EV-associated form of this toxin. To address this point, C. jejuni mutants lacking each of the three CDT subunits (A, B, and C) were generated. C. jejuni cdtA, cdtB, and cdtC bacteria released EVs in similar numbers and sizes to wild-type bacteria, ranging from 5 to 530 nm (mean ± SEM = 118 ±6.9 nm). As the CdtAC subunits mediate toxin binding to host cells, we performed “surface shearing” experiments, in which EVs were treated with proteinase K and incubated with host cells. These experiments indicated that CDT subunits are internal to EVs and that surface proteins are probably not involved in EV-host cell interactions. Furthermore, glycan array studies demonstrated that EVs bind complex host cell glycans and share receptor binding specificities with C. jejuni bacteria for fucosyl GM1 ganglioside, P1 blood group antigen, sialyl, and sulfated Lewis x . Finally, we show that EVs from C. jejuni WT but not mutant bacteria induce cell cycle arrest in epithelial cells. In conclusion, we propose that EVs are an important mechanism for CDT release by C. jejuni and are likely to play a significant role in toxin delivery to host cells. IMPORTANCE: Campylobacter jejuni is the leading cause of foodborne gastroenteritis in humans worldwide and a significant cause of childhood mortality due to diarrheal disease in developing countries. A major factor by which C. jejuni causes disease is a toxin, called cytolethal distending toxin (CDT). The biology of this toxin, however, is poorly understood. In this study, we report that C. jejuni CDT is protected within membrane blebs, known as extracellular vesicles (EVs), released by the bacterium. We showed that proteins on the surfaces of EVs are not required for EV uptake by host cells. Furthermore, we identified several sugar receptors that may be required for EV binding to host cells. By studying the EV-associated form of C. jejuni CDT, we will gain a greater understanding of how C. jejuni intoxicates host cells and how EV-associated CDT may be used in various therapeutic applications, including as anti-tumor therapies.